USANA Health Sciences, Inc. (USNA)

NYSE: USNA · Real-Time Price · USD

14.87

+0.15 (1.02%)

At close: Nov 3, 2026, 4:00 PM EST

12.98

-1.89 (-12.71%)

Pre-market: Nov 4, 2026, 4:35 AM EST

USANA Health Sciences Balance Sheet

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 3, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Cash & Equivalents	178.92	158.38	181.77	330.42	288.42	239.83
Cash & Short-Term Investments	178.92	158.38	181.77	330.42	288.42	239.83
Cash Growth	23.09%	-12.87%	-44.99%	14.56%	20.26%	-23.11%
Other Receivables	-	9.11	8.22	7.2	7.21	7.16
Receivables	5.03	9.11	8.22	7.2	7.21	7.16
Inventory	84.08	102.61	69.74	61.45	67.09	98.32
Prepaid Expenses	22.22	12.55	13.76	11.39	11.38	13.85
Other Current Assets	-	5.77	5.7	7.28	10.28	5.95
Total Current Assets	290.24	288.41	279.19	417.75	384.38	365.12
Property, Plant & Equipment	94.6	111.54	111.12	107.68	111.69	120.07
Long-Term Investments	-	20	-	-	-	-
Goodwill	109.26	137.96	144.17	17.1	17.37	17.67
Other Intangible Assets	120.41	133.15	151.82	29.92	32.43	30.44
Long-Term Deferred Tax Assets	29.79	27.21	19.64	13.28	9.8	4.84
Other Long-Term Assets	64.17	24.65	42.25	47.03	40.88	39.6
Total Assets	708.47	742.92	748.19	632.76	596.55	577.74

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 3, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Accounts Payable	17.66	17.26	11.98	10.07	11.05	13.51
Accrued Expenses	-	75.41	79.57	80.84	84.26	97.63
Short-Term Debt	-	14	23	0.79	-	-
Current Portion of Leases	-	5.65	6.01	7.28	6.89	7.08
Current Income Taxes Payable	-	3.37	3.71	3.3	4.97	5.19
Current Unearned Revenue	-	10.64	12.05	13.91	20.88	19.64
Other Current Liabilities	94.59	2.24	3.3	2.66	15.79	17.75
Total Current Liabilities	112.25	128.57	139.63	118.85	143.83	160.79
Long-Term Leases	-	12.31	10.19	5.14	7.68	10.22
Long-Term Deferred Tax Liabilities	4.86	4.89	4.07	4.55	4.07	7.5
Other Long-Term Liabilities	21.26	10.88	7.97	7.02	6.49	4.11
Total Liabilities	138.38	156.64	161.86	135.56	162.08	182.62

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 3, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Common Stock	526.76	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	-	83.54	75.82	65.66	55.6	50.01
Retained Earnings	-	465.72	478.94	445.22	391.64	344.64
Comprehensive Income & Other	-	-16.18	-22.67	-13.7	-12.79	0.46
Total Common Equity	526.76	533.1	532.11	497.2	434.47	395.12
Minority Interest	43.33	53.17	54.22	-	-	-
Shareholders' Equity	570.1	586.27	586.33	497.2	434.47	395.12
Total Liabilities & Equity	708.47	742.92	748.19	632.76	596.55	577.74

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 3, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Total Debt	-	31.96	39.2	13.21	14.57	17.3
Net Cash (Debt)	178.92	126.42	142.56	317.22	273.85	222.54
Net Cash Growth	23.09%	-11.32%	-55.06%	15.84%	23.06%	-23.38%
Net Cash Per Share	9.71	6.81	7.44	16.40	14.18	10.94
Filing Date Shares Outstanding	18.5	18.46	18.9	19.24	19.29	19.32
Total Common Shares Outstanding	18.5	18.28	19.06	19.13	19.21	19.39
Working Capital	177.99	159.84	139.56	298.9	240.55	204.33
Book Value Per Share	28.48	29.16	27.91	25.99	22.62	20.37
Tangible Book Value	297.09	261.99	236.12	450.18	384.67	347.01
Tangible Book Value Per Share	16.06	14.33	12.39	23.53	20.03	17.89
Land	-	6.65	6.36	6.72	6.72	6.99
Buildings	-	78.59	76.68	77.8	78.07	80.82
Machinery	-	123.82	121.16	116.82	113.99	111.47
Leasehold Improvements	-	10.84	12.61	14.34	14.39	15.21

SEC Filings: 10-K · 10-Q